Ignite Creation Date:
2025-12-24 @ 1:58 PM
Ignite Modification Date:
2026-01-10 @ 2:04 PM
Study NCT ID:
NCT06883695
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-12
First Post:
2025-03-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy Subjects
Sponsor:
Guangdong Hengrui Pharmaceutical Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-08
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10
Completion Date Type:
ESTIMATED
First Submit Date:
2025-03-13
First Submit QC Date:
None
Study First Post Date:
2025-03-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-11
Last Update Post Date:
2025-08-12
Last Update Post Date Type:
ACTUAL